Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$13.64

0.07 (0.52%)

18:29
12/08/19
12/08
18:29
12/08/19
18:29

FT500 data validates Fate Therapeutics' platform, says Piper Jaffray

Piper Jaffray analyst Edward Tenthoff called the NK cell FT500 data reported this weekend at the ASH meeting by Fate Therapeutics "platform validating," adding that in addition to the efficacy reported to date that the safety remains "exceptionally clean." The company also reported "surprise early FT516 data," noted Tenthoff, who pointed out that both iPSC NK cell therapies have exhibited a clean safety profile. He maintains an Overweight rating and $28 price target on Fate shares.

FATE Fate Therapeutics
$13.64

0.07 (0.52%)

11/06/19
WELS
11/06/19
DOWNGRADE
Target $16
WELS
Market Perform
Fate Therapeutics downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough downgraded Fate Therapeutics to Market Perform from Outperform with a $16 price target.
11/06/19
WELS
11/06/19
DOWNGRADE
Target $16
WELS
Market Perform
Wells Fargo downgrades Fate Therapeutics, cuts target to $16 from $24
Wells Fargo analyst Jim Birchenough downgraded Fate Therapeutics to Market Perform from Outperform with a price target of $16, down from $24. Following the company's Q3 update, the analyst believes it development path makes assessment of efficacy more difficult and could extend and complicate timelines to approval. The decision to prioritize combination therapy trials for FT500, FT516 and FT596 before fully assessing monotherapy activity "may take away clearer nearer catalysts and make interpretation of relative benefit more difficult," Birchenough tells investors in a research note. In the near term, he does not expect Fate's monotherapy efforts to yield meaningful efficacy.
11/06/19
MZHO
11/06/19
NO CHANGE
Target $27
MZHO
Buy
Mizuho backs Buy rating on Fate Therapeutics after competitor downgrade
Mizuho analyst Mara Goldstein attributes today's 10% slide in shares of Fate Therapeutics to a competing firm's downgrade of the stock based on their view of the development path for iPSC-derived NK therapies. With FT516 being explored in combination with rituximab and ahead of FT596, Goldstein sees an opportunity for Fate to gain insight into the effects of combination with rituximab and assess this strategy for FT596, the analyst tells investors. She maintains a Buy rating and $27 price target on Fate shares. The Fly notes that Wells Fargo analyst Jim Birchenough downgraded Fate Therapeutics to Market Perform from Outperform this morning with a price target of $16, down from $24.
11/12/19
RHCO
11/12/19
INITIATION
Target $25
RHCO
Buy
Fate Therapeutics initiated with a Buy at SunTrust
SunTrust analyst Robyn Karnauskas initiated coverage of Fate Therapeutics with a Buy rating and $25 price target. The analyst cites investor "excitement" about the potentially "broad applicability" for the company's therapeutics platform in cancer treatment, with more data points set to emerge in 2020.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,493.75

8.83 (0.59%)

, GOOGL

Alphabet Class A

$1,491.00

8.3 (0.56%)

13:00
01/22/20
01/22
13:00
01/22/20
13:00
Periodicals
Alphabet's Pichai sees major potential in healthcare market for AI, Reuters says »

Alphabet and Google CEO…

GOOG

Alphabet

$1,493.75

8.83 (0.59%)

GOOGL

Alphabet Class A

$1,491.00

8.3 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

13:00
01/22/20
01/22
13:00
01/22/20
13:00
General news
U.S. corporate bond update: Adobe launched a $3.15 B 4-part deal »

U.S. corporate bond…

AMZN

Amazon.com

$1,895.31

3.03 (0.16%)

12:58
01/22/20
01/22
12:58
01/22/20
12:58
Hot Stocks
Mark Cuban says Amazon.com remains largest holding »

Mark Cuban said on CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 30

    Jan

  • 10

    Feb

12:55
01/22/20
01/22
12:55
01/22/20
12:55
Conference/Events
Stephens food analysts to hold an analyst/industry conference call »

Analysts provide an…

12:55
01/22/20
01/22
12:55
01/22/20
12:55
Conference/Events
Senate Impeachment Trial of President Trump--Day 3 »

The Senate impeachment…

NTDOY

Nintendo

$0.00

(0.00%)

12:51
01/22/20
01/22
12:51
01/22/20
12:51
Periodicals
Nintendo wins court case in Germany over pre-orders, Nintendo Everything says »

Nintendo has prevailed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$318.56

2.17 (0.69%)

, GOOG

Alphabet

$1,493.73

8.81 (0.59%)

12:48
01/22/20
01/22
12:48
01/22/20
12:48
Periodicals
Google researchers find multiple security flaws in Apple's Safari, FT reports »

Researchers at Google…

AAPL

Apple

$318.56

2.17 (0.69%)

GOOG

Alphabet

$1,493.73

8.81 (0.59%)

GOOGL

Alphabet Class A

$1,491.43

8.73 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 28

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

ARWR

Arrowhead

$48.17

0.54 (1.13%)

12:45
01/22/20
01/22
12:45
01/22/20
12:45
Options
Arrowhead call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

MSI

Motorola Solutions

$177.26

0.29 (0.16%)

12:44
01/22/20
01/22
12:44
01/22/20
12:44
Periodicals
Motorola presales for foldable 'revived' Razr begin January 26, Engadget says »

After delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$331.71

0.39 (0.12%)

12:44
01/22/20
01/22
12:44
01/22/20
12:44
Periodicals
French minister says France, U.S. agree on digital tax framework, AP reports »

France intends to delay…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$331.71

0.39 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:37
01/22/20
01/22
12:37
01/22/20
12:37
Conference/Events
Wolfe Research utilities/midstream analysts to hold luncheon meeting »

Utilities & Power…

CMCSA

Comcast

$47.44

0.13 (0.27%)

12:35
01/22/20
01/22
12:35
01/22/20
12:35
Periodicals
Olympic qualifiers moved or canceled due to coronavirus, CNN reports »

The International Olympic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DIS

Disney

$143.99

0.46 (0.32%)

12:33
01/22/20
01/22
12:33
01/22/20
12:33
Hot Stocks
Scopely acquires FoxNext Games, Cold Iron Studios from Disney »

Scopely and The Walt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

, PUGOY

Peugeot

$0.00

(0.00%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Periodicals
Fiat Chrysler CEO says PSA deal talks 'progressing really well,' Reuters says »

Fiat Chrysler (FCAU) CEO…

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

PUGOY

Peugeot

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.66

0.345 (6.49%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Conference/Events
The Executives' Club of Chicago to hold a luncheon meeting »

The Executives' Club…

SRPT

Sarepta

$121.03

-1.65 (-1.34%)

12:24
01/22/20
01/22
12:24
01/22/20
12:24
Periodicals
New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says »

New documents released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$1.96

0.04 (2.08%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Hot Stocks
Proteostasis to present data from organoid study in CF treatment »

Proteostasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNA

Moderna

$21.97

1 (4.77%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Recommendations
Moderna analyst commentary  »

Moderna mRNA technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/22/20
01/22
12:15
01/22/20
12:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude hit…

TWLO

Twilio

$119.62

0.47 (0.39%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
Periodicals
Breaking Periodicals news story on Twilio »

Hedgeye adds Twilio to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 24

    Feb

NFLX

Netflix

$332.00

-6.24 (-1.84%)

, IBM

IBM

$143.22

4.07 (2.92%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rebounding…

NFLX

Netflix

$332.00

-6.24 (-1.84%)

IBM

IBM

$143.22

4.07 (2.92%)

AAPL

Apple

$318.43

2.04 (0.64%)

ETN

Eaton

$97.23

2.72 (2.88%)

ABT

Abbott

$92.33

2.57 (2.86%)

NAVI

Navient

$15.02

1.16 (8.37%)

ARNC

Arconic

$28.60

-0.795 (-2.71%)

FCEL

FuelCell

$2.14

-0.735 (-25.61%)

NTRS

Northern Trust

$102.32

-6.35 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 27

    Jan

  • 28

    Jan

  • 04

    Feb

NTDOY

Nintendo

$0.00

(0.00%)

12:09
01/22/20
01/22
12:09
01/22/20
12:09
Periodicals
Judge says iLife's patent suit against Nintendo not valid, Verge says »

Federal Judge Barbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.